Medical Devices

Global Overactive Bladder Drug Market Size, Status and Forecast 2018-2025

  • QYR2791693
  • 93 Pages
  • October 2018
  • Medical Devices
Download Sample    Get Discount   
 
In 2017, the global Overactive Bladder Drug market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2018-2025.

This report focuses on the global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Overactive Bladder Drug development in United States, Europe and China.

The key players covered in this study

Astellas Pharma, Inc. (Japan)

Pfizer, Inc. (U.S.)

Teva Pharmaceutical Industries Limited (Israel)

Allergan, Plc (Ireland)

Medtronic plc (Ireland)

Mylan N.V. (U.S.)

Endo International plc (Ireland)

Hisamitsu Pharmaceutical Co., Inc. (Japan)

Sanofi (France)

Apotex, Inc. (Canada)

Cogentix Medical, Inc. (U.S.)

Aurobindo Pharma Limited (India)

Market segment by Type, the product can be split into

Anticholinergics

Solifenacin

Oxybutynin

Darifenacin

Fesoterodine

Tolterodine

Trospium

Others

Market segment by Application, split into

Idiopathic Bladder Overactivity

Neurogenic Bladder Overactivity

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Overactive Bladder Drug status, future forecast, growth opportunity, key market and key players.

To present the Overactive Bladder Drug development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Overactive Bladder Drug are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Players Covered

1.4 Market Analysis by Type

1.4.1 Global Overactive Bladder Drug Market Size Growth Rate by Type (2013-2025)

1.4.2 Anticholinergics

1.4.3 Solifenacin

1.4.4 Oxybutynin

1.4.5 Darifenacin

1.4.6 Fesoterodine

1.4.7 Tolterodine

1.4.8 Trospium

1.4.9 Others

1.5 Market by Application

1.5.1 Global Overactive Bladder Drug Market Share by Application (2013-2025)

1.5.2 Idiopathic Bladder Overactivity

1.5.3 Neurogenic Bladder Overactivity

1.6 Study Objectives

1.7 Years Considered

2 Global Growth Trends

2.1 Overactive Bladder Drug Market Size

2.2 Overactive Bladder Drug Growth Trends by Regions

2.2.1 Overactive Bladder Drug Market Size by Regions (2013-2025)

2.2.2 Overactive Bladder Drug Market Share by Regions (2013-2018)

2.3 Industry Trends

2.3.1 Market Top Trends

2.3.2 Market Drivers

2.3.3 Market Opportunities

3 Market Share by Key Players

3.1 Overactive Bladder Drug Market Size by Manufacturers

3.1.1 Global Overactive Bladder Drug Revenue by Manufacturers (2013-2018)

3.1.2 Global Overactive Bladder Drug Revenue Market Share by Manufacturers (2013-2018)

3.1.3 Global Overactive Bladder Drug Market Concentration Ratio (CR5 and HHI)

3.2 Overactive Bladder Drug Key Players Head office and Area Served

3.3 Key Players Overactive Bladder Drug Product/Solution/Service

3.4 Date of Enter into Overactive Bladder Drug Market

3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

4.1 Global Overactive Bladder Drug Market Size by Type (2013-2018)

4.2 Global Overactive Bladder Drug Market Size by Application (2013-2018)

5 United States

5.1 United States Overactive Bladder Drug Market Size (2013-2018)

5.2 Overactive Bladder Drug Key Players in United States

5.3 United States Overactive Bladder Drug Market Size by Type

5.4 United States Overactive Bladder Drug Market Size by Application

6 Europe

6.1 Europe Overactive Bladder Drug Market Size (2013-2018)

6.2 Overactive Bladder Drug Key Players in Europe

6.3 Europe Overactive Bladder Drug Market Size by Type

6.4 Europe Overactive Bladder Drug Market Size by Application

7 China

7.1 China Overactive Bladder Drug Market Size (2013-2018)

7.2 Overactive Bladder Drug Key Players in China

7.3 China Overactive Bladder Drug Market Size by Type

7.4 China Overactive Bladder Drug Market Size by Application

8 Japan

8.1 Japan Overactive Bladder Drug Market Size (2013-2018)

8.2 Overactive Bladder Drug Key Players in Japan

8.3 Japan Overactive Bladder Drug Market Size by Type

8.4 Japan Overactive Bladder Drug Market Size by Application

9 Southeast Asia

9.1 Southeast Asia Overactive Bladder Drug Market Size (2013-2018)

9.2 Overactive Bladder Drug Key Players in Southeast Asia

9.3 Southeast Asia Overactive Bladder Drug Market Size by Type

9.4 Southeast Asia Overactive Bladder Drug Market Size by Application

10 India

10.1 India Overactive Bladder Drug Market Size (2013-2018)

10.2 Overactive Bladder Drug Key Players in India

10.3 India Overactive Bladder Drug Market Size by Type

10.4 India Overactive Bladder Drug Market Size by Application

11 Central & South America

11.1 Central & South America Overactive Bladder Drug Market Size (2013-2018)

11.2 Overactive Bladder Drug Key Players in Central & South America

11.3 Central & South America Overactive Bladder Drug Market Size by Type

11.4 Central & South America Overactive Bladder Drug Market Size by Application

12 International Players Profiles

12.1 Astellas Pharma, Inc. (Japan)

12.1.1 Astellas Pharma, Inc. (Japan) Company Details

12.1.2 Company Description and Business Overview

12.1.3 Overactive Bladder Drug Introduction

12.1.4 Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)

12.1.5 Astellas Pharma, Inc. (Japan) Recent Development

12.2 Pfizer, Inc. (U.S.)

12.2.1 Pfizer, Inc. (U.S.) Company Details

12.2.2 Company Description and Business Overview

12.2.3 Overactive Bladder Drug Introduction

12.2.4 Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)

12.2.5 Pfizer, Inc. (U.S.) Recent Development

12.3 Teva Pharmaceutical Industries Limited (Israel)

12.3.1 Teva Pharmaceutical Industries Limited (Israel) Company Details

12.3.2 Company Description and Business Overview

12.3.3 Overactive Bladder Drug Introduction

12.3.4 Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2013-2018)

12.3.5 Teva Pharmaceutical Industries Limited (Israel) Recent Development

12.4 Allergan, Plc (Ireland)

12.4.1 Allergan, Plc (Ireland) Company Details

12.4.2 Company Description and Business Overview

12.4.3 Overactive Bladder Drug Introduction

12.4.4 Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)

12.4.5 Allergan, Plc (Ireland) Recent Development

12.5 Medtronic plc (Ireland)

12.5.1 Medtronic plc (Ireland) Company Details

12.5.2 Company Description and Business Overview

12.5.3 Overactive Bladder Drug Introduction

12.5.4 Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)

12.5.5 Medtronic plc (Ireland) Recent Development

12.6 Mylan N.V. (U.S.)

12.6.1 Mylan N.V. (U.S.) Company Details

12.6.2 Company Description and Business Overview

12.6.3 Overactive Bladder Drug Introduction

12.6.4 Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)

12.6.5 Mylan N.V. (U.S.) Recent Development

12.7 Endo International plc (Ireland)

12.7.1 Endo International plc (Ireland) Company Details

12.7.2 Company Description and Business Overview

12.7.3 Overactive Bladder Drug Introduction

12.7.4 Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)

12.7.5 Endo International plc (Ireland) Recent Development

12.8 Hisamitsu Pharmaceutical Co., Inc. (Japan)

12.8.1 Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details

12.8.2 Company Description and Business Overview

12.8.3 Overactive Bladder Drug Introduction

12.8.4 Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)

12.8.5 Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development

12.9 Sanofi (France)

12.9.1 Sanofi (France) Company Details

12.9.2 Company Description and Business Overview

12.9.3 Overactive Bladder Drug Introduction

12.9.4 Sanofi (France) Revenue in Overactive Bladder Drug Business (2013-2018)

12.9.5 Sanofi (France) Recent Development

12.10 Apotex, Inc. (Canada)

12.10.1 Apotex, Inc. (Canada) Company Details

12.10.2 Company Description and Business Overview

12.10.3 Overactive Bladder Drug Introduction

12.10.4 Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2013-2018)

12.10.5 Apotex, Inc. (Canada) Recent Development

12.11 Cogentix Medical, Inc. (U.S.)

12.12 Aurobindo Pharma Limited (India)

13 Market Forecast 2018-2025

13.1 Market Size Forecast by Regions

13.2 United States

13.3 Europe

13.4 China

13.5 Japan

13.6 Southeast Asia

13.7 India

13.8 Central & South America

13.9 Market Size Forecast by Product (2018-2025)

13.10 Market Size Forecast by Application (2018-2025)

14 Analyst\'s Viewpoints/Conclusions

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Disclaimer

15.3 Author Details

List of Tables and Figures

Table Overactive Bladder Drug Key Market Segments

Table Key Players Overactive Bladder Drug Covered

Table Global Overactive Bladder Drug Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Overactive Bladder Drug Market Size Market Share by Type 2013-2025

Figure Anticholinergics Figures

Table Key Players of Anticholinergics

Figure Solifenacin Figures

Table Key Players of Solifenacin

Figure Oxybutynin Figures

Table Key Players of Oxybutynin

Figure Darifenacin Figures

Table Key Players of Darifenacin

Figure Fesoterodine Figures

Table Key Players of Fesoterodine

Figure Tolterodine Figures

Table Key Players of Tolterodine

Figure Trospium Figures

Table Key Players of Trospium

Figure Others Figures

Table Key Players of Others

Table Global Overactive Bladder Drug Market Size Growth by Application 2013-2025 (Million US$)

Figure Idiopathic Bladder Overactivity Case Studies

Figure Neurogenic Bladder Overactivity Case Studies

Figure Overactive Bladder Drug Report Years Considered

Table Global Overactive Bladder Drug Market Size 2013-2025 (Million US$)

Figure Global Overactive Bladder Drug Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Overactive Bladder Drug Market Size by Regions 2013-2025 (Million US$)

Table Global Overactive Bladder Drug Market Size by Regions 2013-2018 (Million US$)

Table Global Overactive Bladder Drug Market Share by Regions 2013-2018

Figure Global Overactive Bladder Drug Market Share by Regions 2013-2018

Figure Global Overactive Bladder Drug Market Share by Regions 2018

Table Market Top Trends

Table Global Overactive Bladder Drug Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Overactive Bladder Drug Market Share by Manufacturers (2013-2018)

Figure Global Overactive Bladder Drug Market Share by Manufacturers in 2018

Table Global Overactive Bladder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Overactive Bladder Drug Product/Solution/Service

Table Date of Enter into Overactive Bladder Drug Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table Global Overactive Bladder Drug Market Size Share by Type (2013-2018)

Figure Global Overactive Bladder Drug Market Size Market Share by Type (2013-2018)

Table Global Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table Global Overactive Bladder Drug Market Size Share by Application (2013-2018)

Figure Global Overactive Bladder Drug Market Size Market Share by Application (2013-2018)

Figure Global Overactive Bladder Drug Revenue Market Share by Application in 2017

Figure United States Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table United States Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table United States Key Players Overactive Bladder Drug Market Share (2017-2018)

Table United States Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table United States Overactive Bladder Drug Market Share by Type (2013-2018)

Table United States Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table United States Overactive Bladder Drug Market Share by Application (2013-2018)

Figure Europe Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table Europe Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table Europe Key Players Overactive Bladder Drug Market Share (2017-2018)

Table Europe Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table Europe Overactive Bladder Drug Market Share by Type (2013-2018)

Table Europe Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table Europe Overactive Bladder Drug Market Share by Application (2013-2018)

Figure China Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table China Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table China Key Players Overactive Bladder Drug Market Share (2017-2018)

Table China Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table China Overactive Bladder Drug Market Share by Type (2013-2018)

Table China Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table China Overactive Bladder Drug Market Share by Application (2013-2018)

Figure Japan Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table Japan Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table Japan Key Players Overactive Bladder Drug Market Share (2017-2018)

Table Japan Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table Japan Overactive Bladder Drug Market Share by Type (2013-2018)

Table Japan Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table Japan Overactive Bladder Drug Market Share by Application (2013-2018)

Figure Southeast Asia Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Overactive Bladder Drug Market Share (2017-2018)

Table Southeast Asia Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Overactive Bladder Drug Market Share by Type (2013-2018)

Table Southeast Asia Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Overactive Bladder Drug Market Share by Application (2013-2018)

Figure India Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table India Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table India Key Players Overactive Bladder Drug Market Share (2017-2018)

Table India Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table India Overactive Bladder Drug Market Share by Type (2013-2018)

Table India Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table India Overactive Bladder Drug Market Share by Application (2013-2018)

Figure Central & South America Overactive Bladder Drug Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Overactive Bladder Drug Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Overactive Bladder Drug Market Share (2017-2018)

Table Central & South America Overactive Bladder Drug Market Size by Type (2013-2018) (Million US$)

Table Central & South America Overactive Bladder Drug Market Share by Type (2013-2018)

Table Central & South America Overactive Bladder Drug Market Size by Application (2013-2018) (Million US$)

Table Central & South America Overactive Bladder Drug Market Share by Application (2013-2018)

Table Astellas Pharma, Inc. (Japan) Company Details

Table Astellas Pharma, Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018) (Million US$)

Figure Astellas Pharma, Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Astellas Pharma, Inc. (Japan) Recent Development

Table Pfizer, Inc. (U.S.) Company Details

Table Pfizer, Inc. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Pfizer, Inc. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Pfizer, Inc. (U.S.) Recent Development

Table Teva Pharmaceutical Industries Limited (Israel) Company Details

Table Teva Pharmaceutical Industries Limited (Israel) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Teva Pharmaceutical Industries Limited (Israel) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Teva Pharmaceutical Industries Limited (Israel) Recent Development

Table Allergan, Plc (Ireland) Company Details

Table Allergan, Plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Allergan, Plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Allergan, Plc (Ireland) Recent Development

Table Medtronic plc (Ireland) Company Details

Table Medtronic plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Medtronic plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Medtronic plc (Ireland) Recent Development

Table Mylan N.V. (U.S.) Company Details

Table Mylan N.V. (U.S.) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Mylan N.V. (U.S.) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Mylan N.V. (U.S.) Recent Development

Table Endo International plc (Ireland) Company Details

Table Endo International plc (Ireland) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Endo International plc (Ireland) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Endo International plc (Ireland) Recent Development

Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Company Details

Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Hisamitsu Pharmaceutical Co., Inc. (Japan) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Hisamitsu Pharmaceutical Co., Inc. (Japan) Recent Development

Table Sanofi (France) Company Details

Table Sanofi (France) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Sanofi (France) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Sanofi (France) Recent Development

Table Apotex, Inc. (Canada) Company Details

Table Apotex, Inc. (Canada) Revenue in Overactive Bladder Drug Business (2013-2018)(Million US$)

Figure Apotex, Inc. (Canada) Revenue Growth Rate in Overactive Bladder Drug Business (2013-2018)

Table Apotex, Inc. (Canada) Recent Development

Table Cogentix Medical, Inc. (U.S.) Company Details

Table Aurobindo Pharma Limited (India) Company Details

Table Global Overactive Bladder Drug Market Size by Regions (Million US$) 2018-2025

Figure Global Overactive Bladder Drug Market Size Share by Regions (2018-2025)

Figure Global Overactive Bladder Drug Market Size Share by Regions in 2025

Figure United States Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure Europe Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure China Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure Japan Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure India Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Overactive Bladder Drug Market Size Forecast (2018-2025)(Million USD)

Table Global Overactive Bladder Drug Market Size by Product (2018-2025) (Million US$)

Figure Global Overactive Bladder Drug Market Size by Product (2018-2025)

Figure Global Overactive Bladder Drug Market Size by Product in 2025

Table Global Overactive Bladder Drug Market Size by Application (2018-2025) (Million US$)

Figure Global Overactive Bladder Drug Market Size by Application (2018-2025)

Figure Global Overactive Bladder Drug Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Medical Implants Market By Type (Orthopedic Implants, cardiac implants, Stents, Spinal Implants, Neurostimulators, dental implants, Breast Implants, facial Implants) and By Materials (Metallic, Ceramic, Polymers, Natural) - Global Opportunity Analysis and Industry Forecast, 2014 - 2022

Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...

  • Publish Date: August 21, 2016
  • $5370
Ostomy Drainage Bags Market by Type (Colostomy Bags, Ileostomy Bags, Urostomy Bags, Continent Urostomy Bags, and Continent Ileostomy Bags) - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...

  • Publish Date: December 1, 2016
  • $5370